Institutional investors hold a majority ownership of AGN through the 88.65% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended June 2016, these large investors purchased a net $7.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ICAHN ASSOCIATES HOLDING LLC Bought 3.4 Million shares of Allergan
WELLINGTON MANAGEMENT CO. LLP Bought 3.1 Million shares of Allergan
VERITAS ASSET MANAGEMENT LLP Bought 2.1 Million shares of Allergan